Selumetinib and Olaparib in Solid Tumors

Clinical trial NCT03162627 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03162627
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm of Breast Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Female Genital Organs Malignant Neoplasms of Male Genital Organs Malignant Neoplasms of Thyroid and Other Endocrine Glands

Start date: 2017-08-04
Primary completion: 2026-08-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.